Canada
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no
December 6, 2017Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma
Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …
Decade lifespan difference in Americans and Canadians with cystic fibrosis
March 15, 2017Research and Development Canada, United States, cystic fibrosis
A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …
Quark to set up “largest biotechnology fund in Canada” for $500m
October 18, 2016Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund
Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …
Valeant plots significant investment in Canadian operations
June 20, 2016Manufacturing and Production, Sales and Marketing Canada, Valeant, manufacturing
Valeant Pharmaceuticals (NYSE: VRX) has announced that it plans to expand its Canadian operations with a $27.5 million expansion of …
Raptor’s Procysbi gets Priority Review from Health Canada
March 22, 2016Manufacturing and Production, Research and Development Canada, Health Canada, Procysbi, Raptor Pharmaceutical, genetic condition
Raptor Pharmaceutical (Nasdaq: RPTP) said Canadian regulators have accepted a priority review for its drug to treat a rare genetic …
PTC Therapeutics to file new Phase III data for genetic muscle disorder drug in Canada
March 15, 2016Manufacturing and Production, Research and Development Canada, PTC Therapeutics, Translarna, nonsense mutation Duchenne muscular dystrophy, phase III
PTC Therapeutics (Nasdaq: PTCT) said it does not expect the Canadian regulators to review its trial drug to treat a …
Mylan launches digital adherence programme for heart patients
November 27, 2015Medical Communications Canada, Mavik, Mylan, pharmacies, trandolapril
Mylan has launched an innovative digital medication adherence and engagement program for patients with high blood pressure. The digital programme, called …
Alexion to challenge Canadian price of Soliris in court
September 28, 2015Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris
Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …
Medicago invests big into plant-based vaccines
May 26, 2015Manufacturing and Production, Sales and Marketing Canada, Quebec, medicago, vaccines
Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …
Valeant sprints ahead of Endo to secure Salix
March 18, 2015Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix
Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …
Actavis buys Allergan for $66 billion
November 18, 2014Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger
The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
GSK manufacturing woes continue
July 8, 2014Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing
Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …
Novartis shuts plant in Canada cutting 300 jobs
December 16, 2013Manufacturing and Production, Sales and Marketing Canada, Novartis, Ontario, cuts, lens, manufacturing
Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
